Table 1 Demographic and baseline clinical characteristics of the study Population.
From: An association of Mycoplasma pneumonia with lung function and laboratory parameters
Factors | Total | MPP group | Healthy group | P value |
|---|---|---|---|---|
(n = 101) | (n = 61) | (n = 40) | ||
Gender (n, %) | 0.467 | |||
Male | 46(45.5) | 26(42.6) | 20(50.0) | |
Female | 55(54.5) | 35(57.4) | 20(50.0) | |
Age | 9.5 ± 1.6 | 9.4 ± 1.6 | 9.7 ± 1.6 | 0.404 |
Proportion born prematurely (n, %) | 9 (8.9) | 5 (8.2) | 4 (10.0) | 0.756 |
Tobacco smoke exposure (n, %) | 62 (61.4) | 34 (55.7) | 28 (70.0) | 0.150 |
Oxygen therapy at birth (n, %) | 13 (12.9) | 8 (13.1) | 5 (12.5) | 0.928 |
Nutritional status (n, %) | 0.544 | |||
Underweight | 8 (7.9) | 6 (9.8) | 2 (5.0) | |
Normal | 71 (70.3) | 43 (70.5) | 29 (72.5) | |
Overweight | 11 (10.9) | 5 (8.2) | 6 (15.0) | |
Obesity | 10 (9.9) | 7 (11.5) | 3 (7.5) | |
Days from symptom onset to admission | / | 6.1 ± 2.2 | None | |
Symptom (n, %) | ||||
Fever | 56 | 56 (91.8) | None | |
Diarrhea | 4 | 4 (6.6) | None | |
Rash | 3 | 3 (4.9) | None | |
Chest pain | 2 | 2 (3.3) | None | |
Radiography (n, %) | ||||
Pulmonary consolidation | 12 | 12 (19.67) | None | |
Pleural effusion | 6 | 6 (9.8) | None | |
Patchy infiltrates | 49 | 49 (80.33) | None | |
Routine blood test + CRP | ||||
WBC 10^9/L | 61 | 7.49 ± 2.09 | None | |
NEUT% | 60 | 66.91 ± 8.6 | None | |
LYM% | 56 | 23.79 ± 7.67 | None | |
NEUT 10^9/L | 34 | 4.64 ± 1.55 | None | |
LYM 10^9/L | 29 | 1.59 ± 0.64 | None | |
EO 10^9/L | 27 | 0.19 ± 0.16 | None | |
BASO 10^9/L | 27 | 0.01 ± 0.02 | None | |
RBC 10^12/L | 46 | 4.37 ± 0.46 | None | |
HGB g/L | 61 | 123.02 ± 10.56 | None | |
PLT 10^9/L | 59 | 235 (193, 283) | None | |
CRP mg/L | 57 | 16.46 (6.55, 30.52) | None | |
Blood biochemistry | ||||
TBIL umol/L | 59 | 6.69 ± 2.85 | None | |
DBIL umol/L | 61 | 1.53 ± 0.53 | None | |
TP g/L | 61 | 69.08 ± 4.33 | None | |
ALB g/L | 61 | 40.2 ± 3.04 | None | |
GLB g/L | 61 | 28.88 ± 3.4 | None | |
PA mg/L | 28 | 125.75 ± 19.15 | None | |
ALT U/L | 61 | 15 (11, 20.5) | None | |
AST U/L | 61 | 34 (28.5, 40.5) | None | |
γ-GT U/L | 61 | 14.61 ± 4.12 | None | |
m-AST U/L | 29 | 22.24 ± 52.68 | None | |
ALP U/L | 60 | 159.5 (141.25, 215.25) | None | |
LDH U/L | 61 | 366.79 ± 106.5 | None | |
CK U/L | 61 | 127 (83.5, 191.5) | None | |
TBA umol/L | 61 | 34 (28.5, 40.5) | None | |
CHE KU/L | 61 | 6.42 ± 1.44 | None | |
UREA mmol/L | 61 | 3.47 ± 0.89 | None | |
CRE umol/L | 61 | 36.04 ± 8.49 | None | |
UA umol/L | 61 | 248 (196.5, 313.5) | None | |
K + mmol/L | 61 | 3.95 (3.71, 4.12) | None | |
NA + mmol/L | 61 | 136.13 ± 2.35 | None | |
Cl- mmol/L | 61 | 101.87 ± 3.11 | None | |
Ca mmol/L | 61 | 2.28 (2.18, 2.355) | None | |
TCO2 mmol/L | 61 | 22.81 ± 2.75 | None | |
Mg mmol/L | 61 | 0.9 ± 0.06 | None | |
Sfe umol/L | 34 | 4.39 ± 2.59 | None | |
Pi mmol/L | 34 | 1.33 ± 0.23 | None | |
GLU mmol/L | 58 | 5.92 ± 0.98 | None | |
A/G | 57 | 1.42 ± 0.2 | None | |
TG mmol/L | 52 | 0.805 (0.68, 0.96) | None | |
CHOL mmol/L | 52 | 3.78 ± 0.7 | None | |
HDL mmol/L | 52 | 0.94 ± 0.16 | None | |
LDL mmol/L | 52 | 2.27 ± 0.54 | None | |
Apo-A1 g/L | 52 | 0.99 ± 0.16 | None | |
Apo-Β g/L | 52 | 0.68 ± 0.17 | None |
